Thermo Fisher Scientific Defined Benefit Plan Adjustment, After Tax decreased by 166.7% to -$2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 166.7%, from $3.00M to -$2.00M.
tmo_defined_benefit_plan_adjustment_after_tax| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | -$3.00M | -$3.00M | -$6.00M | -$4.00M | -$1.00M | $1.00M | -$2.00M | -$1.00M | $0.00 | $5.00M | $3.00M | -$2.00M |
| QoQ Change | — | -250.0% | +0.0% | -100.0% | +33.3% | +75.0% | +200.0% | -300.0% | +50.0% | +100.0% | — | -40.0% | -166.7% |
| YoY Change | — | — | — | -400.0% | -33.3% | +66.7% | +116.7% | +50.0% | +0.0% | -100.0% | +350.0% | +400.0% | -166.7% |